153 related articles for article (PubMed ID: 31423249)
1. Cervical cancer evaluated with integrated
Gong J; Wang N; Bian L; Wang M; Ye M; Wen N; Fu M; Fan W; Meng Y
Oncol Lett; 2019 Aug; 18(2):1815-1823. PubMed ID: 31423249
[TBL] [Abstract][Full Text] [Related]
2. Standardized uptake value and apparent diffusion coefficient of endometrial cancer evaluated with integrated whole-body PET/MR: Correlation with pathological prognostic factors.
Shih IL; Yen RF; Chen CA; Chen BB; Wei SY; Chang WC; Sheu BC; Cheng WF; Tseng YH; Chen XJ; Chen CH; Wei LH; Chiang YC; Torng PL; Yen ML; Shih TT
J Magn Reson Imaging; 2015 Dec; 42(6):1723-32. PubMed ID: 25919115
[TBL] [Abstract][Full Text] [Related]
3. High standardized uptake values of
Yang Z; Wu JR; Wei LL; Liao GX; Yang CJ; Jin GQ; Xiao GY; Su DK
Hell J Nucl Med; 2019; 22(2):96-102. PubMed ID: 31273350
[TBL] [Abstract][Full Text] [Related]
4. Prognostic values of ADC
Akkus Yildirim B; Onal C; Erbay G; Cem Guler O; Karadeli E; Reyhan M; Koc Z
J Obstet Gynaecol; 2019 Feb; 39(2):224-230. PubMed ID: 30354907
[TBL] [Abstract][Full Text] [Related]
5. PET/MRI in Cervical Cancer: Associations Between Imaging Biomarkers and Tumor Stage, Disease Progression, and Overall Survival.
Shih IL; Yen RF; Chen CA; Cheng WF; Chen BB; Chang YH; Cheng MF; Shih TT
J Magn Reson Imaging; 2021 Jan; 53(1):305-318. PubMed ID: 32798280
[TBL] [Abstract][Full Text] [Related]
6. Correlation of standardized uptake value and apparent diffusion coefficient in integrated whole-body PET/MRI of primary and recurrent cervical cancer.
Grueneisen J; Beiderwellen K; Heusch P; Buderath P; Aktas B; Gratz M; Forsting M; Lauenstein T; Ruhlmann V; Umutlu L
PLoS One; 2014; 9(5):e96751. PubMed ID: 24804676
[TBL] [Abstract][Full Text] [Related]
7. Correlation between standardized uptake value and apparent diffusion coefficient of neoplastic lesions evaluated with whole-body simultaneous hybrid PET/MRI.
Rakheja R; Chandarana H; DeMello L; Jackson K; Geppert C; Faul D; Glielmi C; Friedman KP
AJR Am J Roentgenol; 2013 Nov; 201(5):1115-9. PubMed ID: 24147485
[TBL] [Abstract][Full Text] [Related]
8. Parameters of simultaneous 18F-FDG-PET/MRI predict tumor stage and several histopathological features in uterine cervical cancer.
Surov A; Meyer HJ; Schob S; Höhn AK; Bremicker K; Exner M; Stumpp P; Purz S
Oncotarget; 2017 Apr; 8(17):28285-28296. PubMed ID: 28423698
[TBL] [Abstract][Full Text] [Related]
9. Value of integrated PET-IVIM MR in assessing metastases in hypermetabolic pelvic lymph nodes in cervical cancer: a multi-parameter study.
Xu C; Du S; Zhang S; Wang B; Dong C; Sun H
Eur Radiol; 2020 May; 30(5):2483-2492. PubMed ID: 32040728
[TBL] [Abstract][Full Text] [Related]
10. Standardized uptake value and metabolic tumor volume measured by ¹⁸F FDG PET/CT are sensitive biomarkers for the presence of lymph node metastasis in patients with cervical carcinoma.
Vural GU; Akkas BE; Demirel BB
Rev Esp Med Nucl Imagen Mol; 2014; 33(5):268-73. PubMed ID: 25018135
[TBL] [Abstract][Full Text] [Related]
11. Measurement of SUVmax plus ADCmin of the primary tumour is a predictor of prognosis in patients with cervical cancer.
Nakamura K; Joja I; Kodama J; Hongo A; Hiramatsu Y
Eur J Nucl Med Mol Imaging; 2012 Feb; 39(2):283-90. PubMed ID: 22072286
[TBL] [Abstract][Full Text] [Related]
12. Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer.
Miccò M; Vargas HA; Burger IA; Kollmeier MA; Goldman DA; Park KJ; Abu-Rustum NR; Hricak H; Sala E
Eur J Radiol; 2014 Jul; 83(7):1169-1176. PubMed ID: 24767630
[TBL] [Abstract][Full Text] [Related]
13. Predictive Role of Preoperative Whole-Body 18F-FDG PET/CT for Risk Stratification of Early-Stage (FIGO I-IIA) Cervical Cancer Patients Treated by Surgery.
Singaram NK; Hulikal N; Manthri R; Chowhan AK
Cureus; 2024 Jan; 16(1):e53107. PubMed ID: 38283777
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of pretreatment 18F-fluorodeoxyglucose uptake in patients with cervical cancer treated with definitive chemoradiotherapy.
Onal C; Reyhan M; Parlak C; Guler OC; Oymak E
Int J Gynecol Cancer; 2013 Jul; 23(6):1104-10. PubMed ID: 23792605
[TBL] [Abstract][Full Text] [Related]
15. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous whole body (18)F-fluorodeoxyglucose positron emission tomography magnetic resonance imaging for evaluation of pediatric cancer: Preliminary experience and comparison with (18)F-fluorodeoxyglucose positron emission tomography computed tomography.
Pugmire BS; Guimaraes AR; Lim R; Friedmann AM; Huang M; Ebb D; Weinstein H; Catalano OA; Mahmood U; Catana C; Gee MS
World J Radiol; 2016 Mar; 8(3):322-30. PubMed ID: 27028112
[TBL] [Abstract][Full Text] [Related]
17. Correlation of Minimum Apparent Diffusion Coefficient and Maximum Standardized Uptake Value of the Primary Tumor with Clinicopathologic Characteristics in Endometrial Cancer.
Sürer Budak E; Toptaş T; Aydın F; Öner AO; Çevikol C; Şimşek T
Mol Imaging Radionucl Ther; 2017 Feb; 26(1):24-32. PubMed ID: 28291007
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of integrated
Yu Y; Zhang L; Sultana B; Wang B; Sun H
BMC Cancer; 2022 Sep; 22(1):947. PubMed ID: 36050751
[TBL] [Abstract][Full Text] [Related]
19. Detection of hematogenous bone metastasis in cervical cancer: 18F-fluorodeoxyglucose-positron emission tomography versus computed tomography and magnetic resonance imaging.
Liu FY; Yen TC; Chen MY; Lai CH; Chang TC; Chou HH; Hong JH; Chen YR; Ng KK
Cancer; 2009 Dec; 115(23):5470-80. PubMed ID: 19739235
[TBL] [Abstract][Full Text] [Related]
20. Correlation of minimum apparent diffusion coefficient with maximum standardized uptake on fluorodeoxyglucose PET-CT in patients with rectal adenocarcinoma.
Er HÇ; Erden A; Küçük NÖ; Geçim E
Diagn Interv Radiol; 2014; 20(2):105-9. PubMed ID: 24100063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
